phone

EU5 Metered Dose Inhaler Devices Market Outlook to 2023

  • Published Date: 01 Aug 2017
  • Number of Pages: 114
  • Category: Healthcare and Medical
  • Country: Europe
EU5 Metered Dose Inhaler Devices Market Outlook to 2023

Summary

GlobalDatas new report, "EU5 Metered Dose Inhaler Devices Market Outlook to 2023", provides key market data on the EU5 Metered Dose Inhaler Devices market. The report provides value, in millions of US dollars, volume (in units) and and average prices (USD) for Metered Dose Inhaler Devices.

The report also provides company shares and distribution shares data for each of these market segments, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

- Market size and company share data for Metered Dose Inhaler Devices.
- Annualized market revenues (USD million) and volume (units) data for each of the market segments. Data is provided from 2009 to 2016 and forecast to 2023.
- 2016 company shares and distribution shares data for each of the market segments.
- Global corporate-level profiles of key companies operating within the EU5 Metered Dose Inhaler Devices market.
- Key players covered include GlaxoSmithKline Plc, AstraZeneca Plc and Boehringer Ingelheim GmbH.

Reasons to buy

- Develop business strategies by identifying the key market segments poised for strong growth in the future.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the market.
- Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and whats the most preferred mode of product distribution - Identify, understand and capitalize.
Publisher Name : GlobalData

2 Introduction 7
2.1 What Is This Report About? 7
2.2 Metered Dose Inhaler Devices Market Segmentation 7
2.3 Definitions of Markets Covered in the Report 7
3 Metered Dose Inhaler Devices Market, EU5 8
3.1 Metered Dose Inhaler Devices Market, EU5, Revenue ($m), 2009-2023 8
3.2 Metered Dose Inhaler Devices Market, EU5, Revenue ($m), 2009-2016 10
3.3 Metered Dose Inhaler Devices Market, EU5, Revenue ($m), 2016-2023 11
3.4 Metered Dose Inhaler Devices Market, EU5, Volume (Units), 2009-2023 12
3.5 Metered Dose Inhaler Devices Market, EU5, Volume (Units), 2009-2016 14
3.6 Metered Dose Inhaler Devices Market, EU5, Volume (Units), 2016-2023 15
3.7 Metered Dose Inhaler Devices Market, EU5, Company Share by Revenue ($m), 2016 16
4 Metered Dose Inhaler Devices Market, France 18
4.1 Metered Dose Inhaler Devices Market, France, Revenue ($m), 2009-2016 18
4.2 Metered Dose Inhaler Devices Market, France, Revenue ($m), 2016-2023 19
4.3 Metered Dose Inhaler Devices Market, France, Volume (Units), 2009-2016 20
4.4 Metered Dose Inhaler Devices Market, France, Volume (Units), 2016-2023 21
4.5 Metered Dose Inhaler Devices Market, France, Average Price ($), 2009-2023 22
4.6 Metered Dose Inhaler Devices Market, France, Distribution Share by Revenue ($m), 2015-2016 23
4.7 Metered Dose Inhaler Devices Market, France, Company Share by Revenue ($m), 2016 24
5 Metered Dose Inhaler Devices Market, Germany 26
5.1 Metered Dose Inhaler Devices Market, Germany, Revenue ($m), 2009-2016 26
5.2 Metered Dose Inhaler Devices Market, Germany, Revenue ($m), 2016-2023 27
5.3 Metered Dose Inhaler Devices Market, Germany, Volume (Units), 2009-2016 28
5.4 Metered Dose Inhaler Devices Market, Germany, Volume (Units), 2016-2023 29
5.5 Metered Dose Inhaler Devices Market, Germany, Average Price ($), 2009-2023 30
5.6 Metered Dose Inhaler Devices Market, Germany, Distribution Share by Revenue ($m), 2015-2016 31
5.7 Metered Dose Inhaler Devices Market, Germany, Company Share by Revenue ($m), 2016 32
6 Metered Dose Inhaler Devices Market, Italy 34
6.1 Metered Dose Inhaler Devices Market, Italy, Revenue ($m), 2009-2016 34
6.2 Metered Dose Inhaler Devices Market, Italy, Revenue ($m), 2016-2023 35
6.3 Metered Dose Inhaler Devices Market, Italy, Volume (Units), 2009-2016 36
6.4 Metered Dose Inhaler Devices Market, Italy, Volume (Units), 2016-2023 37
6.5 Metered Dose Inhaler Devices Market, Italy, Average Price ($), 2009-2023 38
6.6 Metered Dose Inhaler Devices Market, Italy, Distribution Share by Revenue ($m), 2015-2016 39
6.7 Metered Dose Inhaler Devices Market, Italy, Company Share by Revenue ($m), 2016 40
7 Metered Dose Inhaler Devices Market, Spain 42
7.1 Metered Dose Inhaler Devices Market, Spain, Revenue ($m), 2009-2016 42
7.2 Metered Dose Inhaler Devices Market, Spain, Revenue ($m), 2016-2023 43
7.3 Metered Dose Inhaler Devices Market, Spain, Volume (Units), 2009-2016 44
7.4 Metered Dose Inhaler Devices Market, Spain, Volume (Units), 2016-2023 45
7.5 Metered Dose Inhaler Devices Market, Spain, Average Price ($), 2009-2023 46
7.6 Metered Dose Inhaler Devices Market, Spain, Distribution Share by Revenue ($m), 2015-2016 47
7.7 Metered Dose Inhaler Devices Market, Spain, Company Share by Revenue ($m), 2016 48
8 Metered Dose Inhaler Devices Market, United Kingdom 50
8.1 Metered Dose Inhaler Devices Market, United Kingdom, Revenue ($m), 2009-2016 50
8.2 Metered Dose Inhaler Devices Market, United Kingdom, Revenue ($m), 2016-2023 52
8.3 Metered Dose Inhaler Devices Market, United Kingdom, Volume (Units), 2009-2016 53
8.4 Metered Dose Inhaler Devices Market, United Kingdom, Volume (Units), 2016-2023 54
8.5 Metered Dose Inhaler Devices Market, United Kingdom, Average Price ($), 2009-2023 55
8.6 Metered Dose Inhaler Devices Market, United Kingdom, Distribution Share by Revenue ($m), 2015-2016 56
8.7 Metered Dose Inhaler Devices Market, United Kingdom, Company Share by Revenue ($m), 2016 57
9 Overview of Key Companies in EU5 Metered Dose Inhaler Devices Market 59
9.1 GlaxoSmithKline Plc 59
9.1.1 Company Overview 59
9.2 AstraZeneca Plc 59
9.2.1 Company Overview 59
9.3 Boehringer Ingelheim GmbH 59
9.3.1 Company Overview 59
9.4 Pfizer Inc 60
9.4.1 Company Overview 60
9.5 Merck & Co Inc 60
9.5.1 Company Overview 60
10 Metered Dose Inhaler Devices Market Pipeline Products 61
11 Recent Developments 62
11.1 Corporate Communications 62
11.1.1 May 08, 2017: Dr. Stephen S. Lane joins Alcon as Chief Medical Officer and Global Head Franchise Clinical Strategy 62
11.1.2 May 01, 2017: Mylan Nominates Sjoerd Vollebregt for Election to Board of Directors 62
11.1.3 Mar 28, 2017: Mylan Names Former SEC Commissioner Daniel Gallagher as Chief Legal Officer 63
11.1.4 Mar 22, 2017: BioStable Science & Engineering Announces FDA Clearance of the HAART 300 Aortic Annuloplasty Device 63
11.1.5 Mar 06, 2017: Vectura Group: Board Change 64
11.1.6 Feb 28, 2017: Novartis shareholders approve all resolutions proposed by Board of Directors at the Annual General Meeting 65
11.1.7 Dec 14, 2016: Consort Medical: Directorate Change 65
11.1.8 Nov 25, 2016: Consort Medical: CFO Appointment 66
11.1.9 Aug 17, 2016: Consort Medical Announces Directorate Change 66
11.2 Financial Announcements 66
11.2.1 Jun 15, 2017: Consort Medical: Full year results 66
11.2.2 May 31, 2017: Lamellar Biomedical Recruits First Patients into Clinical Study Assessing LAMELLEYE for Treatment of Dry Eye Disease 67
11.2.3 May 10, 2017: Mylan Reports First Quarter 2017 Results 69
11.2.4 Apr 25, 2017: Novartis delivered sales growth across all divisions as growth drivers, including Cosentyx and Entresto, more than offset generic erosion; innovation momentum continued 71
11.2.5 Apr 05, 2017: InVivo Therapeutics Announces New Patient Enrollment into the INSPIRE Study at the Carolinas Medical Center 74
11.2.6 Apr 05, 2017: Successful financial year 2016 for Boehringer Ingelheim 74
11.2.7 Mar 29, 2017: Peer-Reviewed Clinical Study Shows ID Genomics Bacterial Fingerprinting Technology Can Reduce Prescription Errors and Antibiotic Overuse at the Point-of-Care 75
11.2.8 Mar 21, 2017: Vectura Group: Preliminary Results for the nine-month period ended 31 December 2016 77
11.2.9 Mar 21, 2017: Vectura Group Announces Preliminary Results for the nine-month period ended 31 December 2016 79
11.2.10 Mar 01, 2017: Mylan Reports Fourth Quarter and Full Year 2016 Results and Provides 2017 Guidance 80
11.2.11 Jan 25, 2017: Novartis delivered solid 2016 performance, with Growth Products absorbing Gleevec US LOE; innovation momentum continued; announces share buyback 82
11.2.12 Dec 06, 2016: Consort Medical Reports Interim Results Results For The Six Months Ended 31 October 2016 87
11.2.13 Nov 09, 2016: Mylan Reports Third Quarter 2016 Results 88
11.2.14 Oct 25, 2016: Novartis delivered solid third quarter with Growth Products offsetting Gleevec patent expiration; several positive readouts for potential blockbusters 92
11.2.15 Aug 09, 2016: Mylan Reports Strong Second Quarter 2016 Results Including Total Revenues Up 8% 97
11.2.16 Jul 19, 2016: Novartis delivered solid Q2 despite full quarter of US Gleevec generic impact; significant positive innovation news strengthens future growth prospects 100
11.3 Other Significant Developments 105
11.3.1 Feb 16, 2017: Vectura achieves 9 million royalty cap from GSK Ellipta products 105
11.3.2 Jan 26, 2017: Novartis highlights progress towards access and environmental goals in 2016 Corporate Responsibility Performance Report 105
11.3.3 Jan 26, 2017: Achievement of sales milestone for COPD products 106
11.3.4 Jan 11, 2017: Vectura Group: Pre-close update 106
11.3.5 Nov 29, 2016: Novartis Access shares one-year learnings and announces memorandum of understanding with Rwanda 107
11.3.6 Sep 07, 2016: New Scale-Up and Commercial Supply Agreement 108
11.3.7 Aug 03, 2016: Boehringer Ingelheim: Growth in all core businesses 108
12 Appendix 110
12.1 Research Methodology 111
12.1.1 Coverage 111
12.1.2 Secondary Research 111
12.1.3 Primary Research 112
12.1.4 Company Share Analysis 112
12.1.5 Distribution Share Analysis 112
12.1.6 Benchmarking 113
12.2 GlobalData Consulting 113
12.3 Contact Us 114
12.4 Disclaimer 114

List Of Tables


Table 1: Metered Dose Inhaler Devices Market, Cross Country Comparison, EU5, Revenue ($m), USD Constant, 2009-2023 9
Table 2: Metered Dose Inhaler Devices Market, EU5, Revenue ($m), Historic, USD Constant, 2009-2016 10
Table 3: Metered Dose Inhaler Devices Market, EU5, Revenue ($m), Forecast, USD Constant, 2016-2023 11
Table 4: Metered Dose Inhaler Devices Market, EU5, Volume (Units), 2009-2023 13
Table 5: Metered Dose Inhaler Devices Market, EU5, Volume (Units), Historic, 2009-2016 14
Table 6: Metered Dose Inhaler Devices Market, EU5, Volume (Units), Forecast, 2016-2023 15
Table 7: Metered Dose Inhaler Devices Market, EU5, Company Share by Revenue ($m), USD Constant, 2016 17
Table 8: Metered Dose Inhaler Devices Market, France, Revenue ($m), USD Constant, Historic, 2009-2016 18
Table 9: Metered Dose Inhaler Devices Market, France, Revenue ($m), USD Constant, Forecast, 2016-2023 19
Table 10: Metered Dose Inhaler Devices Market, France, Volume (Units), Historic, 2009-2016 20
Table 11: Metered Dose Inhaler Devices Market, France, Volume (Units), Forecast, 2016-2023 21
Table 12: Metered Dose Inhaler Devices Market, France, Average Price ($), Historic, 2009-2016 22
Table 13: Metered Dose Inhaler Devices Market, France, Average Price ($), Forecast, 2016-2023 22
Table 14: Metered Dose Inhaler Devices Market, France, Distribution Share by Revenue ($m), USD Constant, 2015-2016 23
Table 15: Metered Dose Inhaler Devices Market, France, Company Share by Revenue ($m), USD Constant, 2016 25
Table 16: Metered Dose Inhaler Devices Market, Germany, Revenue ($m), USD Constant, Historic, 2009-2016 26
Table 17: Metered Dose Inhaler Devices Market, Germany, Revenue ($m), USD Constant, Forecast, 2016-2023 27
Table 18: Metered Dose Inhaler Devices Market, Germany, Volume (Units), Historic, 2009-2016 28
Table 19: Metered Dose Inhaler Devices Market, Germany, Volume (Units), Forecast, 2016-2023 29
Table 20: Metered Dose Inhaler Devices Market, Germany, Average Price ($), Historic, 2009-2016 30
Table 21: Metered Dose Inhaler Devices Market, Germany, Average Price ($), Forecast, 2016-2023 30
Table 22: Metered Dose Inhaler Devices Market, Germany, Distribution Share by Revenue ($m), USD Constant, 2015-2016 31
Table 23: Metered Dose Inhaler Devices Market, Germany, Company Share by Revenue ($m), USD Constant, 2016 33
Table 24: Metered Dose Inhaler Devices Market, Italy, Revenue ($m), USD Constant, Historic, 2009-2016 34
Table 25: Metered Dose Inhaler Devices Market, Italy, Revenue ($m), USD Constant, Forecast, 2016-2023 35
Table 26: Metered Dose Inhaler Devices Market, Italy, Volume (Units), Historic, 2009-2016 36
Table 27: Metered Dose Inhaler Devices Market, Italy, Volume (Units), Forecast, 2016-2023 37
Table 28: Metered Dose Inhaler Devices Market, Italy, Average Price ($), Historic, 2009-2016 38
Table 29: Metered Dose Inhaler Devices Market, Italy, Average Price ($), Forecast, 2016-2023 38
Table 30: Metered Dose Inhaler Devices Market, Italy, Distribution Share by Revenue ($m), USD Constant, 2015-2016 39
Table 31: Metered Dose Inhaler Devices Market, Italy, Company Share by Revenue ($m), USD Constant, 2016 41
Table 32: Metered Dose Inhaler Devices Market, Spain, Revenue ($m), USD Constant, Historic, 2009-2016 42
Table 33: Metered Dose Inhaler Devices Market, Spain, Revenue ($m), USD Constant, Forecast, 2016-2023 43
Table 34: Metered Dose Inhaler Devices Market, Spain, Volume (Units), Historic, 2009-2016 44
Table 35: Metered Dose Inhaler Devices Market, Spain, Volume (Units), Forecast, 2016-2023 45
Table 36: Metered Dose Inhaler Devices Market, Spain, Average Price ($), Historic, 2009-2016 46
Table 37: Metered Dose Inhaler Devices Market, Spain, Average Price ($), Forecast, 2016-2023 46
Table 38: Metered Dose Inhaler Devices Market, Spain, Distribution Share by Revenue ($m), USD Constant, 2015-2016 47
Table 39: Metered Dose Inhaler Devices Market, Spain, Company Share by Revenue ($m), USD Constant, 2016 49
Table 40: Metered Dose Inhaler Devices Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2009-2016 51
Table 41: Metered Dose Inhaler Devices Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2016-2023 52
Table 42: Metered Dose Inhaler Devices Market, United Kingdom, Volume (Units), Historic, 2009-2016 53
Table 43: Metered Dose Inhaler Devices Market, United Kingdom, Volume (Units), Forecast, 2016-2023 54
Table 44: Metered Dose Inhaler Devices Market, United Kingdom, Average Price ($), Historic, 2009-2016 55
Table 45: Metered Dose Inhaler Devices Market, United Kingdom, Average Price ($), Forecast, 2016-2023 55
Table 46: Metered Dose Inhaler Devices Market, United Kingdom, Distribution Share by Revenue ($m), USD Constant, 2015-2016 56
Table 47: Metered Dose Inhaler Devices Market, United Kingdom, Company Share by Revenue ($m), USD Constant, 2016 58
Table 48: Metered Dose Inhaler Devices Market Pipeline Products 61

List Of Figures


Figure 1: Metered Dose Inhaler Devices Market, Cross Country Comparison, EU5, Revenue ($m), USD Constant, 2009-2023 8
Figure 2: Metered Dose Inhaler Devices Market, EU5, Revenue ($m), Historic, USD Constant, 2009-2016 10
Figure 3: Metered Dose Inhaler Devices Market, EU5, Revenue ($m), Forecast, USD Constant, 2016-2023 11
Figure 4: Metered Dose Inhaler Devices Market, EU5, Volume (Units), 2009-2023 12
Figure 5: Metered Dose Inhaler Devices Market, EU5, Volume (Units), Historic, 2009-2016 14
Figure 6: Metered Dose Inhaler Devices Market, EU5, Volume (Units), Forecast, 2016-2023 15
Figure 7: Metered Dose Inhaler Devices Market, EU5, Company Share (%) 2016 16
Figure 8: Metered Dose Inhaler Devices Market, France, Revenue ($m), USD Constant, Historic, 2009-2016 18
Figure 9: Metered Dose Inhaler Devices Market, France, Revenue ($m), USD Constant, Forecast, 2016-2023 19
Figure 10: Metered Dose Inhaler Devices Market, France, Volume (Units), Historic, 2009-2016 20
Figure 11: Metered Dose Inhaler Devices Market, France, Volume (Units), Forecast, 2016-2023 21
Figure 12: Metered Dose Inhaler Devices Market, France, Company Share (%) 2016 24
Figure 13: Metered Dose Inhaler Devices Market, Germany, Revenue ($m), USD Constant, Historic, 2009-2016 26
Figure 14: Metered Dose Inhaler Devices Market, Germany, Revenue ($m), USD Constant, Forecast, 2016-2023 27
Figure 15: Metered Dose Inhaler Devices Market, Germany, Volume (Units), Historic, 2009-2016 28
Figure 16: Metered Dose Inhaler Devices Market, Germany, Volume (Units), Forecast, 2016-2023 29
Figure 17: Metered Dose Inhaler Devices Market, Germany, Company Share (%) 2016 32
Figure 18: Metered Dose Inhaler Devices Market, Italy, Revenue ($m), USD Constant, Historic, 2009-2016 34
Figure 19: Metered Dose Inhaler Devices Market, Italy, Revenue ($m), USD Constant, Forecast, 2016-2023 35
Figure 20: Metered Dose Inhaler Devices Market, Italy, Volume (Units), Historic, 2009-2016 36
Figure 21: Metered Dose Inhaler Devices Market, Italy, Volume (Units), Forecast, 2016-2023 37
Figure 22: Metered Dose Inhaler Devices Market, Italy, Company Share (%) 2016 40
Figure 23: Metered Dose Inhaler Devices Market, Spain, Revenue ($m), USD Constant, Historic, 2009-2016 42
Figure 24: Metered Dose Inhaler Devices Market, Spain, Revenue ($m), USD Constant, Forecast, 2016-2023 43
Figure 25: Metered Dose Inhaler Devices Market, Spain, Volume (Units), Historic, 2009-2016 44
Figure 26: Metered Dose Inhaler Devices Market, Spain, Volume (Units), Forecast, 2016-2023 45
Figure 27: Metered Dose Inhaler Devices Market, Spain, Company Share (%) 2016 48
Figure 28: Metered Dose Inhaler Devices Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2009-2016 50
Figure 29: Metered Dose Inhaler Devices Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2016-2023 52
Figure 30: Metered Dose Inhaler Devices Market, United Kingdom, Volume (Units), Historic, 2009-2016 53
Figure 31: Metered Dose Inhaler Devices Market, United Kingdom, Volume (Units), Forecast, 2016-2023 54
Figure 32: Metered Dose Inhaler Devices Market, United Kingdom, Company Share (%) 2016 57

EU5 Metered Dose Inhaler Devices Market Outlook to 2023 GlobalDatas new report, EU5 Metered Dose Inhaler Devices Market Outlook to 2023 , provides key market data on the EU5 Metered Dose Inhaler

View Report

EU5 Infusion Systems Market Outlook to 2023 GlobalDatas new report, EU5 Infusion Systems Market Outlook to 2023 , provides key market data on the EU5 Infusion Systems market. The report provides value,

View Report

EU5 Needle Free Injections Market Outlook to 2023 GlobalDatas new report, EU5 Needle Free Injections Market Outlook to 2023 , provides key market data on the EU5 Needle Free Injections market. The

View Report

Select License Type

Delivery Details

Delivery Details : Electronic files (PDF) of market research reports will dispatched within 12 to 24 hours. (Mon-Fri IST)

Customized Report

If a particular report is not as per your requirement you can ‎choose "Customized Report". To visit click on -

Custom Research Reports